the daily number of tests it was conducting daily that drew the ire of the high court. hence, the cumulative number of tests cannot be corroborated. the daily positivity rate for number of tests conducted by telangana state on june 30 comes to 27.33%. on 30 june, the telangana state conducted 3457 tests, out of which the positive cases were 945. testing as per telangana government media bulletin dated 31-jul-2020, number of testing facilities in the state are as below. type government private rt-pcr/cbnaat/truenat 16 23 rapid antigen testing centers 320 status of tests in the state is as below. date no of samples tested cumulative reports awaited 23 july 2020 3,22,326 24 july 2020 15,445 3,37,771 25 july 2020 15,654 3,53,425 26 july 2020 9,817 3,63,242 27 july 2020 15,839 3,79,081 809 28 july 2020 18,858 3,97,939 788 30 july 2020 21,380 4,37,582 1,216 31 july 2020 21,011 4,58,593 883 1 august 2020 19,202 4,77,795 1,656 2 august 2020 9,443 4,87,238 1,414 3 august 2020 13,787 5,01,025 919 4 august 2020 21,118 5,22,143 1,167 5 august 2020 21,346 5,43,489 1,550 6 august 2020 23,495 5,66,984 1,539 7 august 2020 23,322 5,90,306 1,596 8 august 2020 22,925 6,13,231 1,509 9 august 2020 11,609 6,24,840 1,700 10 august 2020 18,035 6,42,875 959 11 august 2020 22,972 6,65,847 1,221 12 august 2020 23,303 6,89,150 706 13 august 2020 22,046 7,11,196 1151 14 august 2020 21,239 7,32,435 664 summary of test results samples tested 4,531,153 positive 247,284 positive % 5.46% tests per million people 228,684 as of 5 november 2020 response as on 27 july, more than 60% of covid-19 victims of the state had been buried in a single graveyard named faqeer mullah kabristan on the outskirts of hyderabad. covid-19 vaccines with approval for emergency or conditional usage union minister for health & family welfare, dr. harsh vardhan visiting the gtb hospital, shahdara to review the preparedness of dry run of covid-19 vaccine, in delhi on january 02, 2021. main article: covid-19 vaccine covishield on january 1, 2021, the drug controller general of india, approved the emergency or conditional use of astrazeneca's covid-19 vaccine azd1222 (marketed as covishield). covishield is developed by the university of oxford and its spin-out company, vaccitech. it's a viral vector vaccine based on replication-deficient adenovirus that causes cold in chimpanzees. it can be stored, transported and handled at normal refrigerated conditions (two-eight degrees celsius/ 36-46 degrees fahrenheit). it has a shelf-life of at least six months. on 12 january 2021 first batches of covishield vaccine was despatched from the serum institute of india. covaxin on january 2, 2021, bbv152 (marketed as covaxin), first indigenous vaccine, developed by bharat biotech in association with the indian council of medical research and national institute of virology received approval from the drug controller general of india for its emergency or conditional usage. on 14 january 2021 first batches of covaxin vaccine was despatched from the bharat biotech, albeit it was still in the third phase of testing. others on 19 may 2021, dr reddy's labs received emergency use authorisation for anti-covid drug 2-dg. on 21 february, 2022, drugs controller general of india granted approval to biological e's covid-19 vaccine corbevax, that can be used for children between 12 and 18 years of age. on 21 october 2021, india completed administering of one billion covid vaccines in the country. on 8 january 2022, india crossed 1.5 billion covid vaccines milestone in the country. on 19 february 2022, india crossed 1.75 billion covid vaccines milestone in the country. vaccination on 12 january 2021, a consignment of 3.64 lakh doses of oxford-astrazeneca's covishield vaccine arrived in hyderabad from pune. along with 3.64 lakh doses of covishield, manufactured by serum institute of india, the telangana health department has received 20,000 doses of bharat biotech's covaxin on 13 january 2021. s kistamma, a female sanitation worker at the gandhi hospital in secunderabad, became the first person in telangana to receive the covid-19 vaccination on the morning of 16 january 2020.